Education
About Us
Working with TipRanks
Follow Us
AC Immune SA (ACIU)
NASDAQ:ACIU
[18F]Aci-19626
Amyotrophic Lateral Sclerosis (Als), Alzheimer's Disease (Ad), Frontotemporal Dementia (Ftd), Tdp-43 Proteinopathies, Suspected Limbic Predominant Age-Related Tdp-43 Encephalopathy (Late)
Early Phase I
Recruiting
[18F]ACI-19626 PET in TDP-43 Proteinopathies
Mar 18, 2025
―
[18F]Aci-15916
Parkinson's Disease (Pd), Multiple System Atrophy (Msa), Dementia With Lewy Bodies (Dlb)
Early Phase I
Recruiting
[18F]ACI-15916 PET in α-synucleinopathies
Mar 18, 2025
―
Aci-24.060 At Dose A, Aci-24.060 At Dose B, Aci-24.060 At Dose C, Aci-24.060 At Dose D, Aci-24.060 At Dose X, Aci-24.060 At Dose Y
Alzheimer's Disease, Prodromal Alzheimer's Disease, Amyloid Plaque, Beta-Amyloid, Alzheimer's Disease In Down Syndrome
Phase I/II
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Jul 12, 2022
―
Aci-35.030, Jaci-35.054
Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Cognitive Impairment, Brain Diseases, Central Nervous System Diseases, Tauopathies
Phase I/II
Completed
A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease
Jun 22, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AC Immune SA (ACIU) have in its pipeline
ACIU is currently developing the following drugs: [18F]Aci-19626, [18F]Aci-15916, Aci-24.060 At Dose A, Aci-24.060 At Dose B, Aci-24.060 At Dose C, Aci-24.060 At Dose D, Aci-24.060 At Dose X, Aci-24.060 At Dose Y. These drug candidates are in various stages of clinical development as the company works toward FDA approval.